Navigation Links
Second Quarter Health Care M&A Strongest In Years According To New Report From Irving Levin Associates, Inc.
Date:7/9/2008

NORWALK, Conn., July 9 /PRNewswire/ -- According to a new Report from Irving Levin Associates, a total of 265 mergers and acquisitions were announced in the health care industry during the second quarter of 2008, a 19% increase from the 223 deals announced in the prior quarter. Based on preliminary figures, a total of $85.5 billion was committed to fund the second quarter's M&A activity, a 209% increase over the prior quarter's $27.7 billion. It is also a 25% increase over the $68.3 billion spent in Q2:06 and a 39% increase over the $61.3 billion spent in Q2:07. Despite the slow-down in global M&A, activity in the health care industry is robust and on the rise.

The Health Care M&A Market Second Quarter 2008

Dollar Amounts By Sector*

Dollar Amount Percent of

Second Quarter Quarter

Sector 2008

Home Health Care $1,658,700,000 2 %

Hospitals 644,000,000 <1 %

Long-Term Care 361,750,000 <1 %

Labs, MRI, Dialysis 29,587,000 <1 %

Managed Care 14,500,000 <1 %

Rehabilitation 9,500,000 <1 %

Behavioral Health Care 0 -

Physician Medical Groups 0 -

Other Services 2,118,558,000 3 %

Services subtotal $4,807,008,000 6 %

Medical Devices $53,347,291,000 63 %

Biotechnology 16,316,388,000 19 %

Pharmaceuticals 8,207,938,000 9 %

e-Health 2,817,300,000 3 %

Technology subtotal $80,688,917,000 94 %

Total health care $85,495,925,000 100 %

*Preliminary figures

The health care technology segment attracted the largest amount of capital, capturing nearly 95 cents out of every dollar invested in health care M&A. This portion is up from the first quarter when 80 cents out of every health care M&A dollar was spent in the technology sectors.

The number of deals announced in each sector of the health care industry appears in the chart below, along with comparisons to the prior quarter (Q1:08) and the year-ago quarter (Q2:07).

The Health Care M&A Market Q2:08 - Deal Volume By Sector

Q2:08 Q1:08 % Q2:07 %

Sector Deals* Deals Change Deals Change

Services Segment:

Long-Term Care 21 28 -25% 27 -22%

Physician Groups 12 12 0% 6 100%

Home Health Care 13 11 18% 18 -28%

Hospitals 12 10 20% 15 -20%

Labs, MRI, Dialysis 8 10 -20% 12 -33%

Managed Care 3 7 -57% 9 -67%

Rehabilitation 4 6 -33% 4 0%

Behavioral Health

Care 3 3 0% 3 0%

Other 34 23 48% 27 26%

Services Subtotal 110 110 0% 121 -9%

Technology Segment:

Medical Devices 51 35 46% 40 28%

Pharmaceuticals 38 34 12% 39 -3%

Biotechnology 46 29 59% 37 24%

e-Health 20 15 33% 15 33%

Technology Subtotal 155 113 37% 131 18%

Grand Total 265 223 19% 252 5%

*Preliminary figures

These results point to a resurgence of interest in health care M&A despite a lackluster start at the beginning of the year. "After a lethargic first quarter, both deal and dollar volume in the health care M&A market surged in the second," stated Sanford Steever, Ph.D., editor of The Health Care M&A Report. "Given the relative absence of financial buyers from the market, a greater number of strategic buyers now feel more confident in entering the market," added Mr. Steever.

The Health Care industry continues to attract more interest from potential deal makers than other sectors of the economy. "The combination of health care and technology is proving irresistible for investors and operators looking to enter the M&A market," commented Stephen M. Monroe, managing editor at Irving Levin Associates. "While sectors such as Medical Devices and Biotechnology are obvious magnets for M&A dollars, so too are technologically-oriented services sectors such as Infusion Therapy and Contract Research Organizations."

"Though not completely insulated from the surrounding economy and its influence, the health care M&A market appears to run on an internal logic of its own and to have access to sufficient capital to make it happen," Mr. Steever summarized. "Deals in health care technology will likely drive the market for the remainder of the year."

For more information on The Health Care M&A Report, or for a subscription to any Irving Levin publications, call 800-248-1668. Irving Levin Associates, Inc., established in 1948, has headquarters in Norwalk, CT and is online at http://www.levinassociates.com. This privately held corporation publishes research reports and newsletters, and maintains merger and acquisition and venture capital databases, on the health care and senior housing markets.


'/>"/>
SOURCE Irving Levin Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Response Genetics Reports Second Quarter 2007 Financial Results
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Transgenomic, Inc. Reports Second Quarter 2007 Results
10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
11. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):